nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—NR3C1—type 2 diabetes mellitus	0.195	0.466	CbGaD
Betamethasone—CYP3A4—type 2 diabetes mellitus	0.113	0.27	CbGaD
Betamethasone—PTGS2—type 2 diabetes mellitus	0.11	0.264	CbGaD
Betamethasone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0404	0.133	CbGbCtD
Betamethasone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.036	0.118	CbGbCtD
Betamethasone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.026	0.0854	CbGbCtD
Betamethasone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0242	0.0794	CbGbCtD
Betamethasone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0215	0.0708	CbGbCtD
Betamethasone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0197	0.0648	CbGbCtD
Betamethasone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0179	0.0587	CbGbCtD
Betamethasone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0172	0.0566	CbGbCtD
Betamethasone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0156	0.0512	CbGbCtD
Betamethasone—ABCB1—Glyburide—type 2 diabetes mellitus	0.0133	0.0437	CbGbCtD
Betamethasone—ABCB1—Losartan—type 2 diabetes mellitus	0.0122	0.04	CbGbCtD
Betamethasone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0118	0.0388	CbGbCtD
Betamethasone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0113	0.0372	CbGbCtD
Betamethasone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0113	0.0372	CbGbCtD
Betamethasone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0107	0.0352	CbGbCtD
Betamethasone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00798	0.0262	CbGbCtD
Betamethasone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00729	0.024	CbGbCtD
Betamethasone—PLA2G1B—islet of Langerhans—type 2 diabetes mellitus	0.00215	0.0699	CbGeAlD
Betamethasone—PGR—artery—type 2 diabetes mellitus	0.00206	0.0669	CbGeAlD
Betamethasone—PTGS2—leg—type 2 diabetes mellitus	0.00188	0.061	CbGeAlD
Betamethasone—PTGS2—hindlimb—type 2 diabetes mellitus	0.00168	0.0545	CbGeAlD
Betamethasone—PLA2G1B—cardiovascular system—type 2 diabetes mellitus	0.00155	0.0505	CbGeAlD
Betamethasone—PLA2G1B—kidney—type 2 diabetes mellitus	0.00152	0.0494	CbGeAlD
Betamethasone—PLA2G1B—pancreas—type 2 diabetes mellitus	0.00151	0.0491	CbGeAlD
Betamethasone—NR3C1—nerve—type 2 diabetes mellitus	0.00118	0.0383	CbGeAlD
Betamethasone—PTGS2—artery—type 2 diabetes mellitus	0.00103	0.0334	CbGeAlD
Betamethasone—NR3C2—retina—type 2 diabetes mellitus	0.000909	0.0296	CbGeAlD
Betamethasone—PTGS2—endothelium—type 2 diabetes mellitus	0.000868	0.0282	CbGeAlD
Betamethasone—NR3C2—nephron tubule—type 2 diabetes mellitus	0.000856	0.0279	CbGeAlD
Betamethasone—NR3C2—cardiovascular system—type 2 diabetes mellitus	0.000769	0.025	CbGeAlD
Betamethasone—NR3C2—kidney—type 2 diabetes mellitus	0.000753	0.0245	CbGeAlD
Betamethasone—NR3C2—cortex of kidney—type 2 diabetes mellitus	0.000733	0.0238	CbGeAlD
Betamethasone—PGR—cardiovascular system—type 2 diabetes mellitus	0.000715	0.0233	CbGeAlD
Betamethasone—NR3C2—adipose tissue—type 2 diabetes mellitus	0.000678	0.0221	CbGeAlD
Betamethasone—PGR—adipose tissue—type 2 diabetes mellitus	0.000631	0.0205	CbGeAlD
Betamethasone—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.00057	0.0186	CbGeAlD
Betamethasone—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000567	0.0185	CbGeAlD
Betamethasone—Prednisone—HSD11B1—type 2 diabetes mellitus	0.000533	0.0971	CrCbGaD
Betamethasone—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000494	0.0161	CbGeAlD
Betamethasone—NR3C2—liver—type 2 diabetes mellitus	0.000476	0.0155	CbGeAlD
Betamethasone—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000459	0.0149	CbGeAlD
Betamethasone—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000413	0.0134	CbGeAlD
Betamethasone—NR3C1—kidney—type 2 diabetes mellitus	0.000404	0.0131	CbGeAlD
Betamethasone—NR3C1—pancreas—type 2 diabetes mellitus	0.000401	0.013	CbGeAlD
Betamethasone—CYP19A1—liver—type 2 diabetes mellitus	0.000398	0.0129	CbGeAlD
Betamethasone—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.000393	0.0128	CbGeAlD
Betamethasone—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000364	0.0118	CbGeAlD
Betamethasone—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000357	0.0116	CbGeAlD
Betamethasone—PTGS2—kidney—type 2 diabetes mellitus	0.000349	0.0114	CbGeAlD
Betamethasone—PTGS2—pancreas—type 2 diabetes mellitus	0.000347	0.0113	CbGeAlD
Betamethasone—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000315	0.0102	CbGeAlD
Betamethasone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000305	0.00993	CbGeAlD
Betamethasone—CYP3A4—kidney—type 2 diabetes mellitus	0.000305	0.00993	CbGeAlD
Betamethasone—ABCB1—retina—type 2 diabetes mellitus	0.000261	0.00849	CbGeAlD
Betamethasone—NR3C1—liver—type 2 diabetes mellitus	0.000255	0.0083	CbGeAlD
Betamethasone—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000246	0.008	CbGeAlD
Betamethasone—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000221	0.00718	CbGeAlD
Betamethasone—PTGS2—liver—type 2 diabetes mellitus	0.000221	0.00718	CbGeAlD
Betamethasone—ABCB1—kidney—type 2 diabetes mellitus	0.000216	0.00703	CbGeAlD
Betamethasone—ABCB1—pancreas—type 2 diabetes mellitus	0.000215	0.00698	CbGeAlD
Betamethasone—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.00021	0.00685	CbGeAlD
Betamethasone—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000195	0.00634	CbGeAlD
Betamethasone—CYP3A4—liver—type 2 diabetes mellitus	0.000193	0.00628	CbGeAlD
Betamethasone—Difluprednate—NR3C1—type 2 diabetes mellitus	0.000164	0.0299	CrCbGaD
Betamethasone—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000159	0.029	CrCbGaD
Betamethasone—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000159	0.029	CrCbGaD
Betamethasone—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000151	0.0274	CrCbGaD
Betamethasone—Desonide—NR3C1—type 2 diabetes mellitus	0.000151	0.0274	CrCbGaD
Betamethasone—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000147	0.0268	CrCbGaD
Betamethasone—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000145	0.0264	CrCbGaD
Betamethasone—Fludrocortisone—AR—type 2 diabetes mellitus	0.000143	0.0261	CrCbGaD
Betamethasone—ABCB1—liver—type 2 diabetes mellitus	0.000137	0.00444	CbGeAlD
Betamethasone—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.000135	0.0246	CrCbGaD
Betamethasone—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.000129	0.0234	CrCbGaD
Betamethasone—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000126	0.023	CrCbGaD
Betamethasone—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000124	0.0227	CrCbGaD
Betamethasone—Fluoxymesterone—AR—type 2 diabetes mellitus	0.000118	0.0215	CrCbGaD
Betamethasone—Budesonide—NR3C1—type 2 diabetes mellitus	0.000116	0.0211	CrCbGaD
Betamethasone—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000116	0.0211	CrCbGaD
Betamethasone—Fluticasone furoate—NR3C1—type 2 diabetes mellitus	0.000113	0.0207	CrCbGaD
Betamethasone—Mometasone—NR3C1—type 2 diabetes mellitus	0.00011	0.02	CrCbGaD
Betamethasone—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000109	0.0198	CrCbGaD
Betamethasone—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000107	0.000667	CcSEcCtD
Betamethasone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000106	0.000663	CcSEcCtD
Betamethasone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000106	0.000661	CcSEcCtD
Betamethasone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000106	0.000661	CcSEcCtD
Betamethasone—Hypertension—Metformin—type 2 diabetes mellitus	0.000105	0.000657	CcSEcCtD
Betamethasone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000105	0.000657	CcSEcCtD
Betamethasone—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000105	0.000657	CcSEcCtD
Betamethasone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000105	0.000654	CcSEcCtD
Betamethasone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000105	0.000654	CcSEcCtD
Betamethasone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000104	0.000652	CcSEcCtD
Betamethasone—Anorexia—Valsartan—type 2 diabetes mellitus	0.000104	0.000651	CcSEcCtD
Betamethasone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000649	CcSEcCtD
Betamethasone—Myalgia—Metformin—type 2 diabetes mellitus	0.000104	0.000648	CcSEcCtD
Betamethasone—Malaise—Irbesartan—type 2 diabetes mellitus	0.000104	0.000648	CcSEcCtD
Betamethasone—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000103	0.000646	CcSEcCtD
Betamethasone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000103	0.000645	CcSEcCtD
Betamethasone—Syncope—Irbesartan—type 2 diabetes mellitus	0.000103	0.000644	CcSEcCtD
Betamethasone—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000103	0.000642	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000103	0.000641	CcSEcCtD
Betamethasone—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000103	0.0187	CrCbGaD
Betamethasone—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.000103	0.0187	CrCbGaD
Betamethasone—Discomfort—Metformin—type 2 diabetes mellitus	0.000103	0.000641	CcSEcCtD
Betamethasone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000103	0.00064	CcSEcCtD
Betamethasone—Nausea—Glipizide—type 2 diabetes mellitus	0.000102	0.000638	CcSEcCtD
Betamethasone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000102	0.000638	CcSEcCtD
Betamethasone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000102	0.000638	CcSEcCtD
Betamethasone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000102	0.000636	CcSEcCtD
Betamethasone—Pain—Gliclazide—type 2 diabetes mellitus	0.000102	0.000635	CcSEcCtD
Betamethasone—Rash—Glimepiride—type 2 diabetes mellitus	0.000101	0.000632	CcSEcCtD
Betamethasone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000101	0.000632	CcSEcCtD
Betamethasone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000101	0.000632	CcSEcCtD
Betamethasone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000101	0.00063	CcSEcCtD
Betamethasone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000101	0.00063	CcSEcCtD
Betamethasone—Headache—Glimepiride—type 2 diabetes mellitus	0.000101	0.000628	CcSEcCtD
Betamethasone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.0001	0.000628	CcSEcCtD
Betamethasone—Headache—Sitagliptin—type 2 diabetes mellitus	0.0001	0.000626	CcSEcCtD
Betamethasone—Alclometasone—NR3C1—type 2 diabetes mellitus	9.97e-05	0.0182	CrCbGaD
Betamethasone—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	9.97e-05	0.0182	CrCbGaD
Betamethasone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.95e-05	0.000622	CcSEcCtD
Betamethasone—Oedema—Metformin—type 2 diabetes mellitus	9.95e-05	0.000621	CcSEcCtD
Betamethasone—Hypertension—Irbesartan—type 2 diabetes mellitus	9.93e-05	0.00062	CcSEcCtD
Betamethasone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.91e-05	0.000619	CcSEcCtD
Betamethasone—Angioedema—Losartan—type 2 diabetes mellitus	9.89e-05	0.000618	CcSEcCtD
Betamethasone—Infection—Metformin—type 2 diabetes mellitus	9.89e-05	0.000617	CcSEcCtD
Betamethasone—Insomnia—Valsartan—type 2 diabetes mellitus	9.88e-05	0.000617	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.84e-05	0.000614	CcSEcCtD
Betamethasone—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.81e-05	0.000613	CcSEcCtD
Betamethasone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.8e-05	0.000612	CcSEcCtD
Betamethasone—Myalgia—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.000612	CcSEcCtD
Betamethasone—Shock—Metformin—type 2 diabetes mellitus	9.79e-05	0.000611	CcSEcCtD
Betamethasone—Insomnia—Orlistat—type 2 diabetes mellitus	9.77e-05	0.00061	CcSEcCtD
Betamethasone—Malaise—Losartan—type 2 diabetes mellitus	9.76e-05	0.00061	CcSEcCtD
Betamethasone—Anxiety—Irbesartan—type 2 diabetes mellitus	9.76e-05	0.00061	CcSEcCtD
Betamethasone—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.76e-05	0.000609	CcSEcCtD
Betamethasone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.74e-05	0.000609	CcSEcCtD
Betamethasone—Vertigo—Losartan—type 2 diabetes mellitus	9.73e-05	0.000608	CcSEcCtD
Betamethasone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.72e-05	0.000607	CcSEcCtD
Betamethasone—Syncope—Losartan—type 2 diabetes mellitus	9.71e-05	0.000606	CcSEcCtD
Betamethasone—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	9.7e-05	0.0177	CrCbGaD
Betamethasone—Fludrocortisone—NR3C1—type 2 diabetes mellitus	9.7e-05	0.0177	CrCbGaD
Betamethasone—Flunisolide—NR3C1—type 2 diabetes mellitus	9.7e-05	0.0177	CrCbGaD
Betamethasone—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.69e-05	0.000606	CcSEcCtD
Betamethasone—Discomfort—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.000604	CcSEcCtD
Betamethasone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.62e-05	0.000601	CcSEcCtD
Betamethasone—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.62e-05	0.000601	CcSEcCtD
Betamethasone—Paramethasone—NR3C1—type 2 diabetes mellitus	9.58e-05	0.0175	CrCbGaD
Betamethasone—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.58e-05	0.000598	CcSEcCtD
Betamethasone—Nausea—Glimepiride—type 2 diabetes mellitus	9.54e-05	0.000596	CcSEcCtD
Betamethasone—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.53e-05	0.000595	CcSEcCtD
Betamethasone—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.52e-05	0.000594	CcSEcCtD
Betamethasone—Nausea—Sitagliptin—type 2 diabetes mellitus	9.51e-05	0.000594	CcSEcCtD
Betamethasone—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.5e-05	0.000594	CcSEcCtD
Betamethasone—Asthenia—Glyburide—type 2 diabetes mellitus	9.5e-05	0.000594	CcSEcCtD
Betamethasone—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.5e-05	0.000593	CcSEcCtD
Betamethasone—Anorexia—Metformin—type 2 diabetes mellitus	9.48e-05	0.000592	CcSEcCtD
Betamethasone—Urticaria—Gliclazide—type 2 diabetes mellitus	9.45e-05	0.00059	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.43e-05	0.000589	CcSEcCtD
Betamethasone—Alopecia—Ramipril—type 2 diabetes mellitus	9.42e-05	0.000589	CcSEcCtD
Betamethasone—Fatigue—Valsartan—type 2 diabetes mellitus	9.42e-05	0.000588	CcSEcCtD
Betamethasone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.4e-05	0.000587	CcSEcCtD
Betamethasone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.4e-05	0.000587	CcSEcCtD
Betamethasone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000587	CcSEcCtD
Betamethasone—Oedema—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000587	CcSEcCtD
Betamethasone—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.39e-05	0.000586	CcSEcCtD
Betamethasone—Pruritus—Glyburide—type 2 diabetes mellitus	9.37e-05	0.000585	CcSEcCtD
Betamethasone—Fluorometholone—NR3C1—type 2 diabetes mellitus	9.35e-05	0.017	CrCbGaD
Betamethasone—Infection—Irbesartan—type 2 diabetes mellitus	9.33e-05	0.000583	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.32e-05	0.000582	CcSEcCtD
Betamethasone—Fatigue—Orlistat—type 2 diabetes mellitus	9.31e-05	0.000581	CcSEcCtD
Betamethasone—Hypotension—Metformin—type 2 diabetes mellitus	9.3e-05	0.000581	CcSEcCtD
Betamethasone—Erythema—Ramipril—type 2 diabetes mellitus	9.28e-05	0.00058	CcSEcCtD
Betamethasone—Shock—Irbesartan—type 2 diabetes mellitus	9.24e-05	0.000577	CcSEcCtD
Betamethasone—Pain—Orlistat—type 2 diabetes mellitus	9.23e-05	0.000577	CcSEcCtD
Betamethasone—Myalgia—Losartan—type 2 diabetes mellitus	9.22e-05	0.000576	CcSEcCtD
Betamethasone—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.21e-05	0.000575	CcSEcCtD
Betamethasone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	9.21e-05	0.000575	CcSEcCtD
Betamethasone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.19e-05	0.000574	CcSEcCtD
Betamethasone—Anxiety—Losartan—type 2 diabetes mellitus	9.19e-05	0.000574	CcSEcCtD
Betamethasone—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000572	CcSEcCtD
Betamethasone—Rash—Bromocriptine—type 2 diabetes mellitus	9.13e-05	0.000571	CcSEcCtD
Betamethasone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.13e-05	0.00057	CcSEcCtD
Betamethasone—Discomfort—Losartan—type 2 diabetes mellitus	9.11e-05	0.000569	CcSEcCtD
Betamethasone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.08e-05	0.000567	CcSEcCtD
Betamethasone—Headache—Bromocriptine—type 2 diabetes mellitus	9.08e-05	0.000567	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.07e-05	0.000566	CcSEcCtD
Betamethasone—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.06e-05	0.000566	CcSEcCtD
Betamethasone—Methylprednisolone—NR3C1—type 2 diabetes mellitus	9.04e-05	0.0165	CrCbGaD
Betamethasone—Anorexia—Irbesartan—type 2 diabetes mellitus	8.95e-05	0.000559	CcSEcCtD
Betamethasone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.93e-05	0.000558	CcSEcCtD
Betamethasone—Paraesthesia—Metformin—type 2 diabetes mellitus	8.93e-05	0.000558	CcSEcCtD
Betamethasone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.9e-05	0.000556	CcSEcCtD
Betamethasone—Oedema—Losartan—type 2 diabetes mellitus	8.84e-05	0.000552	CcSEcCtD
Betamethasone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.84e-05	0.000552	CcSEcCtD
Betamethasone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000551	CcSEcCtD
Betamethasone—Infection—Losartan—type 2 diabetes mellitus	8.78e-05	0.000548	CcSEcCtD
Betamethasone—Hypotension—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.000548	CcSEcCtD
Betamethasone—Dyspepsia—Metformin—type 2 diabetes mellitus	8.76e-05	0.000547	CcSEcCtD
Betamethasone—Shock—Losartan—type 2 diabetes mellitus	8.69e-05	0.000543	CcSEcCtD
Betamethasone—Urticaria—Valsartan—type 2 diabetes mellitus	8.68e-05	0.000542	CcSEcCtD
Betamethasone—Dexamethasone—CYP11A1—type 2 diabetes mellitus	8.67e-05	0.0158	CrCbGaD
Betamethasone—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.67e-05	0.000541	CcSEcCtD
Betamethasone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.65e-05	0.00054	CcSEcCtD
Betamethasone—Decreased appetite—Metformin—type 2 diabetes mellitus	8.65e-05	0.00054	CcSEcCtD
Betamethasone—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.64e-05	0.00054	CcSEcCtD
Betamethasone—Tachycardia—Losartan—type 2 diabetes mellitus	8.62e-05	0.000539	CcSEcCtD
Betamethasone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.61e-05	0.000538	CcSEcCtD
Betamethasone—Nausea—Bromocriptine—type 2 diabetes mellitus	8.61e-05	0.000538	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.59e-05	0.000537	CcSEcCtD
Betamethasone—Fatigue—Metformin—type 2 diabetes mellitus	8.58e-05	0.000536	CcSEcCtD
Betamethasone—Urticaria—Orlistat—type 2 diabetes mellitus	8.58e-05	0.000536	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.56e-05	0.000534	CcSEcCtD
Betamethasone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.54e-05	0.000534	CcSEcCtD
Betamethasone—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.54e-05	0.000533	CcSEcCtD
Betamethasone—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.54e-05	0.000533	CcSEcCtD
Betamethasone—Asthenia—Gliclazide—type 2 diabetes mellitus	8.53e-05	0.000533	CcSEcCtD
Betamethasone—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	8.5e-05	0.0155	CrCbGaD
Betamethasone—Angioedema—Ramipril—type 2 diabetes mellitus	8.48e-05	0.00053	CcSEcCtD
Betamethasone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000527	CcSEcCtD
Betamethasone—Anorexia—Losartan—type 2 diabetes mellitus	8.42e-05	0.000526	CcSEcCtD
Betamethasone—Vomiting—Glyburide—type 2 diabetes mellitus	8.42e-05	0.000526	CcSEcCtD
Betamethasone—Pruritus—Gliclazide—type 2 diabetes mellitus	8.41e-05	0.000526	CcSEcCtD
Betamethasone—Malaise—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000523	CcSEcCtD
Betamethasone—Rash—Glyburide—type 2 diabetes mellitus	8.35e-05	0.000522	CcSEcCtD
Betamethasone—Dermatitis—Glyburide—type 2 diabetes mellitus	8.34e-05	0.000521	CcSEcCtD
Betamethasone—Vertigo—Ramipril—type 2 diabetes mellitus	8.34e-05	0.000521	CcSEcCtD
Betamethasone—Syncope—Ramipril—type 2 diabetes mellitus	8.33e-05	0.00052	CcSEcCtD
Betamethasone—Headache—Glyburide—type 2 diabetes mellitus	8.3e-05	0.000518	CcSEcCtD
Betamethasone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000516	CcSEcCtD
Betamethasone—Hypotension—Losartan—type 2 diabetes mellitus	8.26e-05	0.000516	CcSEcCtD
Betamethasone—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.2e-05	0.000512	CcSEcCtD
Betamethasone—Hydrocortisone—SHBG—type 2 diabetes mellitus	8.2e-05	0.0149	CrCbGaD
Betamethasone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.16e-05	0.00051	CcSEcCtD
Betamethasone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.16e-05	0.00051	CcSEcCtD
Betamethasone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.14e-05	0.000508	CcSEcCtD
Betamethasone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.14e-05	0.000508	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.11e-05	0.000506	CcSEcCtD
Betamethasone—Fatigue—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000506	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.05e-05	0.000503	CcSEcCtD
Betamethasone—Convulsion—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000502	CcSEcCtD
Betamethasone—Pain—Irbesartan—type 2 diabetes mellitus	8.03e-05	0.000502	CcSEcCtD
Betamethasone—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	8.02e-05	0.0146	CrCbGaD
Betamethasone—Insomnia—Losartan—type 2 diabetes mellitus	7.99e-05	0.000499	CcSEcCtD
Betamethasone—Paraesthesia—Losartan—type 2 diabetes mellitus	7.94e-05	0.000496	CcSEcCtD
Betamethasone—Urticaria—Metformin—type 2 diabetes mellitus	7.9e-05	0.000494	CcSEcCtD
Betamethasone—Myalgia—Ramipril—type 2 diabetes mellitus	7.9e-05	0.000494	CcSEcCtD
Betamethasone—Anxiety—Ramipril—type 2 diabetes mellitus	7.88e-05	0.000492	CcSEcCtD
Betamethasone—Nausea—Glyburide—type 2 diabetes mellitus	7.87e-05	0.000491	CcSEcCtD
Betamethasone—Abdominal pain—Metformin—type 2 diabetes mellitus	7.87e-05	0.000491	CcSEcCtD
Betamethasone—Dizziness—Gliclazide—type 2 diabetes mellitus	7.86e-05	0.000491	CcSEcCtD
Betamethasone—Asthenia—Valsartan—type 2 diabetes mellitus	7.84e-05	0.00049	CcSEcCtD
Betamethasone—Discomfort—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000488	CcSEcCtD
Betamethasone—Dyspepsia—Losartan—type 2 diabetes mellitus	7.78e-05	0.000486	CcSEcCtD
Betamethasone—Asthenia—Orlistat—type 2 diabetes mellitus	7.75e-05	0.000484	CcSEcCtD
Betamethasone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.74e-05	0.000483	CcSEcCtD
Betamethasone—Pruritus—Valsartan—type 2 diabetes mellitus	7.73e-05	0.000483	CcSEcCtD
Betamethasone—Decreased appetite—Losartan—type 2 diabetes mellitus	7.68e-05	0.00048	CcSEcCtD
Betamethasone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.00048	CcSEcCtD
Betamethasone—Pruritus—Orlistat—type 2 diabetes mellitus	7.64e-05	0.000477	CcSEcCtD
Betamethasone—Triamcinolone—NR3C1—type 2 diabetes mellitus	7.62e-05	0.0139	CrCbGaD
Betamethasone—Fatigue—Losartan—type 2 diabetes mellitus	7.62e-05	0.000476	CcSEcCtD
Betamethasone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000473	CcSEcCtD
Betamethasone—Oedema—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000473	CcSEcCtD
Betamethasone—Vomiting—Gliclazide—type 2 diabetes mellitus	7.56e-05	0.000472	CcSEcCtD
Betamethasone—Pain—Losartan—type 2 diabetes mellitus	7.56e-05	0.000472	CcSEcCtD
Betamethasone—Rash—Gliclazide—type 2 diabetes mellitus	7.5e-05	0.000468	CcSEcCtD
Betamethasone—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.49e-05	0.000468	CcSEcCtD
Betamethasone—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.48e-05	0.000467	CcSEcCtD
Betamethasone—Urticaria—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000466	CcSEcCtD
Betamethasone—Shock—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000466	CcSEcCtD
Betamethasone—Headache—Gliclazide—type 2 diabetes mellitus	7.45e-05	0.000465	CcSEcCtD
Betamethasone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.43e-05	0.000464	CcSEcCtD
Betamethasone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000464	CcSEcCtD
Betamethasone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000464	CcSEcCtD
Betamethasone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.42e-05	0.000463	CcSEcCtD
Betamethasone—Tachycardia—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000462	CcSEcCtD
Betamethasone—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.39e-05	0.000461	CcSEcCtD
Betamethasone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000458	CcSEcCtD
Betamethasone—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.28e-05	0.000455	CcSEcCtD
Betamethasone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.23e-05	0.000451	CcSEcCtD
Betamethasone—Dizziness—Valsartan—type 2 diabetes mellitus	7.23e-05	0.000451	CcSEcCtD
Betamethasone—Anorexia—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000451	CcSEcCtD
Betamethasone—Dexamethasone—NOS2—type 2 diabetes mellitus	7.18e-05	0.0131	CrCbGaD
Betamethasone—Dizziness—Orlistat—type 2 diabetes mellitus	7.14e-05	0.000446	CcSEcCtD
Betamethasone—Asthenia—Metformin—type 2 diabetes mellitus	7.14e-05	0.000446	CcSEcCtD
Betamethasone—Hypotension—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000442	CcSEcCtD
Betamethasone—Nausea—Gliclazide—type 2 diabetes mellitus	7.06e-05	0.000441	CcSEcCtD
Betamethasone—Pruritus—Metformin—type 2 diabetes mellitus	7.04e-05	0.00044	CcSEcCtD
Betamethasone—Urticaria—Losartan—type 2 diabetes mellitus	7.02e-05	0.000438	CcSEcCtD
Betamethasone—Abdominal pain—Losartan—type 2 diabetes mellitus	6.99e-05	0.000436	CcSEcCtD
Betamethasone—Body temperature increased—Losartan—type 2 diabetes mellitus	6.99e-05	0.000436	CcSEcCtD
Betamethasone—Vomiting—Valsartan—type 2 diabetes mellitus	6.95e-05	0.000434	CcSEcCtD
Betamethasone—Prednisone—NR3C1—type 2 diabetes mellitus	6.91e-05	0.0126	CrCbGaD
Betamethasone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000431	CcSEcCtD
Betamethasone—Rash—Valsartan—type 2 diabetes mellitus	6.89e-05	0.00043	CcSEcCtD
Betamethasone—Dermatitis—Valsartan—type 2 diabetes mellitus	6.88e-05	0.00043	CcSEcCtD
Betamethasone—Vomiting—Orlistat—type 2 diabetes mellitus	6.86e-05	0.000429	CcSEcCtD
Betamethasone—Insomnia—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000428	CcSEcCtD
Betamethasone—Headache—Valsartan—type 2 diabetes mellitus	6.85e-05	0.000428	CcSEcCtD
Betamethasone—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	6.82e-05	0.0124	CrCbGaD
Betamethasone—Diarrhoea—Metformin—type 2 diabetes mellitus	6.81e-05	0.000425	CcSEcCtD
Betamethasone—Rash—Orlistat—type 2 diabetes mellitus	6.81e-05	0.000425	CcSEcCtD
Betamethasone—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000425	CcSEcCtD
Betamethasone—Dermatitis—Orlistat—type 2 diabetes mellitus	6.8e-05	0.000425	CcSEcCtD
Betamethasone—Headache—Orlistat—type 2 diabetes mellitus	6.76e-05	0.000422	CcSEcCtD
Betamethasone—Asthenia—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000421	CcSEcCtD
Betamethasone—Budesonide—CYP3A4—type 2 diabetes mellitus	6.7e-05	0.0122	CrCbGaD
Betamethasone—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.67e-05	0.000417	CcSEcCtD
Betamethasone—Pruritus—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000415	CcSEcCtD
Betamethasone—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000411	CcSEcCtD
Betamethasone—Dizziness—Metformin—type 2 diabetes mellitus	6.58e-05	0.000411	CcSEcCtD
Betamethasone—Fluticasone furoate—CYP3A4—type 2 diabetes mellitus	6.57e-05	0.012	CrCbGaD
Betamethasone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000409	CcSEcCtD
Betamethasone—Fatigue—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000408	CcSEcCtD
Betamethasone—Nausea—Valsartan—type 2 diabetes mellitus	6.49e-05	0.000405	CcSEcCtD
Betamethasone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000401	CcSEcCtD
Betamethasone—Nausea—Orlistat—type 2 diabetes mellitus	6.41e-05	0.000401	CcSEcCtD
Betamethasone—Prednisolone—NR3C1—type 2 diabetes mellitus	6.37e-05	0.0116	CrCbGaD
Betamethasone—Asthenia—Losartan—type 2 diabetes mellitus	6.34e-05	0.000396	CcSEcCtD
Betamethasone—Vomiting—Metformin—type 2 diabetes mellitus	6.33e-05	0.000395	CcSEcCtD
Betamethasone—Rash—Metformin—type 2 diabetes mellitus	6.27e-05	0.000392	CcSEcCtD
Betamethasone—Dermatitis—Metformin—type 2 diabetes mellitus	6.27e-05	0.000392	CcSEcCtD
Betamethasone—Pruritus—Losartan—type 2 diabetes mellitus	6.25e-05	0.000391	CcSEcCtD
Betamethasone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.24e-05	0.00039	CcSEcCtD
Betamethasone—Headache—Metformin—type 2 diabetes mellitus	6.23e-05	0.000389	CcSEcCtD
Betamethasone—Dizziness—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000388	CcSEcCtD
Betamethasone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000387	CcSEcCtD
Betamethasone—Diarrhoea—Losartan—type 2 diabetes mellitus	6.05e-05	0.000378	CcSEcCtD
Betamethasone—Urticaria—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000376	CcSEcCtD
Betamethasone—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000374	CcSEcCtD
Betamethasone—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000374	CcSEcCtD
Betamethasone—Vomiting—Irbesartan—type 2 diabetes mellitus	5.97e-05	0.000373	CcSEcCtD
Betamethasone—Rash—Irbesartan—type 2 diabetes mellitus	5.92e-05	0.00037	CcSEcCtD
Betamethasone—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.92e-05	0.000369	CcSEcCtD
Betamethasone—Nausea—Metformin—type 2 diabetes mellitus	5.91e-05	0.000369	CcSEcCtD
Betamethasone—Headache—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.000367	CcSEcCtD
Betamethasone—Dizziness—Losartan—type 2 diabetes mellitus	5.84e-05	0.000365	CcSEcCtD
Betamethasone—Alclometasone—CYP3A4—type 2 diabetes mellitus	5.78e-05	0.0105	CrCbGaD
Betamethasone—Flunisolide—CYP3A4—type 2 diabetes mellitus	5.63e-05	0.0102	CrCbGaD
Betamethasone—Vomiting—Losartan—type 2 diabetes mellitus	5.62e-05	0.000351	CcSEcCtD
Betamethasone—Nausea—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000348	CcSEcCtD
Betamethasone—Rash—Losartan—type 2 diabetes mellitus	5.57e-05	0.000348	CcSEcCtD
Betamethasone—Dermatitis—Losartan—type 2 diabetes mellitus	5.57e-05	0.000348	CcSEcCtD
Betamethasone—Paramethasone—CYP3A4—type 2 diabetes mellitus	5.55e-05	0.0101	CrCbGaD
Betamethasone—Headache—Losartan—type 2 diabetes mellitus	5.54e-05	0.000346	CcSEcCtD
Betamethasone—Asthenia—Ramipril—type 2 diabetes mellitus	5.44e-05	0.00034	CcSEcCtD
Betamethasone—Fluorometholone—CYP3A4—type 2 diabetes mellitus	5.42e-05	0.00987	CrCbGaD
Betamethasone—Pruritus—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000335	CcSEcCtD
Betamethasone—Nausea—Losartan—type 2 diabetes mellitus	5.25e-05	0.000328	CcSEcCtD
Betamethasone—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	5.24e-05	0.00955	CrCbGaD
Betamethasone—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000324	CcSEcCtD
Betamethasone—Dizziness—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000313	CcSEcCtD
Betamethasone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	4.87e-05	0.00888	CrCbGaD
Betamethasone—Vomiting—Ramipril—type 2 diabetes mellitus	4.82e-05	0.000301	CcSEcCtD
Betamethasone—Rash—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000298	CcSEcCtD
Betamethasone—Dermatitis—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000298	CcSEcCtD
Betamethasone—Dexamethasone—ABCC2—type 2 diabetes mellitus	4.76e-05	0.00868	CrCbGaD
Betamethasone—Headache—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000296	CcSEcCtD
Betamethasone—Nausea—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000281	CcSEcCtD
Betamethasone—Triamcinolone—CYP3A4—type 2 diabetes mellitus	4.42e-05	0.00805	CrCbGaD
Betamethasone—Triamcinolone—PTGS2—type 2 diabetes mellitus	4.33e-05	0.00788	CrCbGaD
Betamethasone—Prednisone—CYP3A4—type 2 diabetes mellitus	4.01e-05	0.0073	CrCbGaD
Betamethasone—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	3.95e-05	0.0072	CrCbGaD
Betamethasone—Prednisolone—CYP3A4—type 2 diabetes mellitus	3.69e-05	0.00673	CrCbGaD
Betamethasone—Dexamethasone—NR3C1—type 2 diabetes mellitus	3.63e-05	0.00662	CrCbGaD
Betamethasone—Prednisone—ALB—type 2 diabetes mellitus	3.5e-05	0.00637	CrCbGaD
Betamethasone—Dexamethasone—CYP2E1—type 2 diabetes mellitus	3.34e-05	0.00609	CrCbGaD
Betamethasone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	2.83e-05	0.00515	CrCbGaD
Betamethasone—Dexamethasone—CYP3A4—type 2 diabetes mellitus	2.11e-05	0.00384	CrCbGaD
Betamethasone—Dexamethasone—PTGS2—type 2 diabetes mellitus	2.06e-05	0.00376	CrCbGaD
Betamethasone—PGR—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.67e-06	0.000119	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	9.67e-06	0.000119	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	9.59e-06	0.000118	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	9.58e-06	0.000118	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS1—type 2 diabetes mellitus	9.56e-06	0.000118	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	9.49e-06	0.000117	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	9.49e-06	0.000117	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	9.46e-06	0.000116	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	9.32e-06	0.000115	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	9.3e-06	0.000114	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	9.26e-06	0.000114	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.23e-06	0.000113	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	9.17e-06	0.000113	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	9.15e-06	0.000112	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.06e-06	0.000111	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	9.04e-06	0.000111	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.01e-06	0.000111	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	8.99e-06	0.00011	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	8.99e-06	0.00011	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	8.99e-06	0.00011	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	8.96e-06	0.00011	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	8.94e-06	0.00011	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	8.94e-06	0.00011	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	8.94e-06	0.00011	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	8.94e-06	0.00011	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	8.93e-06	0.00011	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	8.85e-06	0.000109	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	8.85e-06	0.000109	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	8.82e-06	0.000108	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	8.74e-06	0.000107	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.73e-06	0.000107	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	8.69e-06	0.000107	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	8.62e-06	0.000106	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	8.59e-06	0.000105	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	8.57e-06	0.000105	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	8.56e-06	0.000105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.55e-06	0.000105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	8.55e-06	0.000105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	8.55e-06	0.000105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	8.55e-06	0.000105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	8.55e-06	0.000105	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—type 2 diabetes mellitus	8.51e-06	0.000105	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—INS—type 2 diabetes mellitus	8.36e-06	0.000103	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	8.28e-06	0.000102	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	8.24e-06	0.000101	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.22e-06	0.000101	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	8.22e-06	0.000101	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.17e-06	0.0001	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	8.13e-06	9.99e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	8.13e-06	9.99e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	8.09e-06	9.95e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.08e-06	9.93e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	8.08e-06	9.93e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.08e-06	9.93e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	7.97e-06	9.79e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	7.93e-06	9.74e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	7.84e-06	9.64e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	7.83e-06	9.62e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.82e-06	9.61e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.82e-06	9.61e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	7.79e-06	9.57e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	7.79e-06	9.57e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	7.7e-06	9.46e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.68e-06	9.43e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	7.67e-06	9.42e-05	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.67e-06	9.42e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOB—type 2 diabetes mellitus	7.65e-06	9.4e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.62e-06	9.36e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	7.58e-06	9.32e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	7.58e-06	9.31e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	7.44e-06	9.14e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.33e-06	9.01e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.33e-06	9.01e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LPL—type 2 diabetes mellitus	7.3e-06	8.97e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	7.29e-06	8.96e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	7.29e-06	8.96e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.27e-06	8.93e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.27e-06	8.93e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.27e-06	8.93e-05	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—type 2 diabetes mellitus	7.23e-06	8.89e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	7.15e-06	8.78e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	7.15e-06	8.78e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	7.1e-06	8.73e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	7.1e-06	8.73e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	7.1e-06	8.73e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	7.06e-06	8.67e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.97e-06	8.56e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.97e-06	8.56e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.93e-06	8.52e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	6.9e-06	8.48e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	6.85e-06	8.42e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	6.85e-06	8.42e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	6.82e-06	8.39e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	6.73e-06	8.27e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CCR5—type 2 diabetes mellitus	6.73e-06	8.27e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	6.72e-06	8.25e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.72e-06	8.25e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.71e-06	8.24e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.71e-06	8.24e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	6.69e-06	8.21e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	6.68e-06	8.21e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	6.6e-06	8.1e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.59e-06	8.1e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	6.57e-06	8.08e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	6.55e-06	8.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.48e-06	7.96e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.48e-06	7.96e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.48e-06	7.96e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	6.4e-06	7.87e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	6.37e-06	7.83e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	6.37e-06	7.83e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	6.37e-06	7.83e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	6.27e-06	7.7e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IRS2—type 2 diabetes mellitus	6.25e-06	7.68e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	6.25e-06	7.68e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	6.23e-06	7.65e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.22e-06	7.65e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	6.2e-06	7.61e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CALM1—type 2 diabetes mellitus	6.14e-06	7.55e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOE—type 2 diabetes mellitus	6.12e-06	7.52e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	6.11e-06	7.51e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.09e-06	7.48e-05	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.08e-06	7.46e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.06e-06	7.45e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOA1—type 2 diabetes mellitus	6.05e-06	7.43e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	6.01e-06	7.38e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	5.99e-06	7.35e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	5.97e-06	7.33e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.88e-06	7.23e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.83e-06	7.16e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.82e-06	7.15e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	5.81e-06	7.14e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.76e-06	7.08e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.76e-06	7.08e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.75e-06	7.06e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	5.75e-06	7.06e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.74e-06	7.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.7e-06	7.01e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS2—type 2 diabetes mellitus	5.7e-06	7.01e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.62e-06	6.9e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.52e-06	6.79e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.52e-06	6.79e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.51e-06	6.77e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.51e-06	6.77e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.51e-06	6.77e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.51e-06	6.77e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	5.51e-06	6.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IRS1—type 2 diabetes mellitus	5.46e-06	6.71e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	5.42e-06	6.66e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	5.4e-06	6.64e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.28e-06	6.49e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.28e-06	6.49e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	5.26e-06	6.46e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	5.23e-06	6.43e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—INS—type 2 diabetes mellitus	5.23e-06	6.42e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	5.18e-06	6.37e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	5.14e-06	6.32e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	5.13e-06	6.3e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	5.07e-06	6.23e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT2—type 2 diabetes mellitus	5.05e-06	6.21e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.91e-06	6.03e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.85e-06	5.95e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	4.8e-06	5.9e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.76e-06	5.85e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.76e-06	5.85e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.75e-06	5.84e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.74e-06	5.82e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.68e-06	5.75e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.58e-06	5.63e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.58e-06	5.63e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.58e-06	5.63e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.54e-06	5.58e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.49e-06	5.52e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.49e-06	5.52e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	4.46e-06	5.49e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.42e-06	5.43e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.4e-06	5.41e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.38e-06	5.38e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.38e-06	5.38e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.38e-06	5.38e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.38e-06	5.38e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.35e-06	5.34e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.33e-06	5.33e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.27e-06	5.25e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.24e-06	5.21e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.23e-06	5.2e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.22e-06	5.19e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.12e-06	5.06e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.07e-06	5e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	4.01e-06	4.93e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.92e-06	4.82e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.92e-06	4.82e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.92e-06	4.82e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.9e-06	4.8e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.85e-06	4.73e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.84e-06	4.72e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	3.84e-06	4.72e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.83e-06	4.7e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.82e-06	4.69e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.74e-06	4.59e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.71e-06	4.56e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	3.65e-06	4.49e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.65e-06	4.48e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.63e-06	4.46e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.59e-06	4.41e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.59e-06	4.41e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.55e-06	4.36e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.55e-06	4.36e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.4e-06	4.18e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.4e-06	4.18e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.39e-06	4.17e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.37e-06	4.14e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.16e-06	3.89e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.1e-06	3.81e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	3.03e-06	3.73e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	3e-06	3.68e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—type 2 diabetes mellitus	2.97e-06	3.65e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.93e-06	3.6e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.93e-06	3.6e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.92e-06	3.59e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.88e-06	3.54e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.85e-06	3.5e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.8e-06	3.44e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.72e-06	3.34e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.72e-06	3.34e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.72e-06	3.34e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.67e-06	3.28e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	2.64e-06	3.25e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.61e-06	3.21e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.61e-06	3.2e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.54e-06	3.12e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.51e-06	3.08e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.49e-06	3.06e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.4e-06	2.95e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.36e-06	2.9e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.28e-06	2.81e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.28e-06	2.81e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.25e-06	2.76e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.24e-06	2.75e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.21e-06	2.72e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—type 2 diabetes mellitus	2.11e-06	2.59e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.95e-06	2.4e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.91e-06	2.35e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.76e-06	2.17e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.75e-06	2.15e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.68e-06	2.06e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.68e-06	2.06e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.53e-06	1.88e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.25e-06	1.54e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.71e-07	9.47e-06	CbGpPWpGaD
